Q: Current thoughts? Outlook for earnings? Is debt an issue? Could pandemic be a catalyst?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Amgen Inc. (AMGN $329.82)
-
Regeneron Pharmaceuticals Inc. (REGN $701.42)
-
AbbVie Inc. (ABBV $206.60)
-
Humana Inc. (HUM $233.63)
-
eHealth Inc. (EHTH $2.04)
Q: I would like your advice on my Healthcare Portfolio. Currently, we own IHI, SYK, PFE, BMY, ZTS , LHCG. My watchlist includes names that you have also recommended. Please rank your top healthcare preferences [could include others] 5 or 6 names overall [ growth at reasonable price, with rationale, if possible.
Q: As a retiree with a balanced portfolio, I hold SIS and wonder if there are better longer term opportunities in this market. I like SIS's demographic market position and strong balance sheet. Covid-19 may entice more seniors to stay at home longer, which could help SIS. But I have concerns. The firm's international growth will challenge their Board and management to deal with greater complexity. They have a new CFO and SIS did not have much to say about the person in their announcement. The CEO owns a large share position, and the company's payout ratio seems high. All in all, I'm wondering if I should move on and sell. What do you think of my assessment? Anything else I should be considering? Thank you.
Edward
Edward
Q: Do you know what has been going on with CRYX during the last month or so. Will it continue ?
Thanks
Ian
Thanks
Ian
Q: Hi 5i,
Thoughts on this newer telemedicine company (CloudMD Software)? Would it be comparable to the services and prospects similar to Well Health Technologies?
Thanks you
Terry
Thoughts on this newer telemedicine company (CloudMD Software)? Would it be comparable to the services and prospects similar to Well Health Technologies?
Thanks you
Terry
Q: It seems a lot of investors are trying to guess which pharmaceutical company will win the vaccine lottery. Assuming there is a vaccine developed by one of these private companies nobody knows what type of profit margin there will be. That seems like a high risk investment strategy to me. Logic suggests that the amount of money I, or my government, will spend to buy my COVID-19 vaccine will pale in comparison with the amount that will we will all spend on PPE, other medical equipment, hand sanitizer, etc, Rather than gamble on which company may win the vaccine lottery wouldn’t it make more sense to invest in XLV or other ETFs which include the companies that are guaranteed to benefit from all of this extra business?
-
Johnson & Johnson (JNJ $227.19)
-
Medtronic plc. (MDT $80.00)
-
UnitedHealth Group Incorporated (DE) (UNH $368.78)
Q: Hi 5i,
Can you provide three US health related stocks that are in different areas of the healthcare field, that you would currently buy?
Thanks
Terry
Can you provide three US health related stocks that are in different areas of the healthcare field, that you would currently buy?
Thanks
Terry
Q: Vaccine developers are something like the Klondike goldrush, numerous companies are hoping to discover the vaccine for this virus and that would make them the next Shopify. I read a lot and especially on US sites. A few companies surfaced recently which could possibly be the next gold discovery (vaccine) which are ARCT, NVAX, DVAX, IBIO and GOVX. Do you recognize any of these and think they could be the next big stock winners in providing a vaccine for the epidemic?
Q: San Diego small cap Sorrento Therapeutics stock exploded on Friday. Sorrento said it's STI-1499 antibody demonstrated 100% inhibition of the COVID-19 virus infection of healthy cells in pre-clinical trials. The company advised full results of the experiment will soon be submitted to a "peer-reviewed publication." A week ago they announced an agreement to work with Mount Sinai Health System on a phase one clinical trial of the retained plasma of 15000 covid patients commencing in Q3.
The company appears to be claiming that STI-1499 at the pre-clinical stage is a cure which they plan to develop as a stand alone treatment as well as the 1st part of an antibody cocktail treatment which they are developing in cooperation with Mount Sinai for the same purpose.
Generally speaking I am an investor, not a gambler but am interested in your views/comments on this company and it's financial situation, which is why I mention the word "gamble". Would you invest/gamble ? on this co. at this stage or sit back and wait for further confirmation of test results.
John
The company appears to be claiming that STI-1499 at the pre-clinical stage is a cure which they plan to develop as a stand alone treatment as well as the 1st part of an antibody cocktail treatment which they are developing in cooperation with Mount Sinai for the same purpose.
Generally speaking I am an investor, not a gambler but am interested in your views/comments on this company and it's financial situation, which is why I mention the word "gamble". Would you invest/gamble ? on this co. at this stage or sit back and wait for further confirmation of test results.
John
-
Teladoc Health Inc. (TDOC $6.46)
-
WELL Health Technologies Corp. (WELL $4.27)
-
Livongo Health Inc. (LVGO $132.68)
Q: I would like your opinion above three stocks. Which One is best for growth wise for 2 to 3 yrs investment
Thx
Thx
Q: Is Quidel worth owning on its merits -- quite apart from the diagnostic testing that's given it an incredible pop in the last month? As a health care play, would you prefer this one over Teladoc, (TDOC) for instance. I realize they are not "exactly equivalent" in terms of their intrinsic businesses, but I am looking for solid growth story in the health field.
-
State Street Health Care Select Sector SPDR ETF (XLV $145.16)
-
iShares U.S. Medical Devices ETF (IHI $50.50)
Q: What would be your ETF choice for US Healthcare?
Q: This name seems to have good earnings and is also working on Covid meds so there's that potential as well. May I have your thoughts please?
Jason
Jason
Q: I'm trying to understand the complicated US Health Care system! Are HUM and UNH competitors? From a stock purchase perspective, would you be buyers of either/both these companies? If not them, what are your favourite health care stocks in the US?
Thanks!
Thanks!
Q: wondering if you would be kind enough to give me your prognosis on this company and mgmt team in particular , please and thank you...Cheers
Q: Please comment on recent earnings.
Q: Comments on their latest quarter? I own a lot "for the dividend" and not happy with the significant drop. However, I believe there must be value in their hospitals which would help them recover as things open up again. How do you see their ability to recover to a sustainable business level?
Q: Can you please give me your opinion on this US mask manufacturer. I would have thought it would be performing better in this environment. Please advise if this is good opportunity to buy now. Thanks
Q: What's your opinion of Jamieson at this point in time?
Q: Hello can you tell me the difference in cloud md and well healths telemedicine approach?